Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 5:00 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2089–2112 of 48,563 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: AS+ Clear all

Conditions: Children Receiving General Anesthesia
Interventions: cardiac monitor; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 1 Hour to 18 Years
Enrollment: 402 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Brain Concussion, Mild Traumatic Brain Injury
Interventions: Physical Therapy; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 13 Years to 65 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Orland Park, Illinois • Niagara Falls, New York

Conditions: Scarring
Interventions: Standard Post Operative Skin Care, Medipore Tape; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 15 Years to 95 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Alzheimer's Disease
Interventions: Nonexercise control group, Aerobic Exercise Group 1, Aerobic Exercise Group 2, Aerobic Exercise Group 3; Behavioral
Lead sponsor: Jeff Burns, MD; Other
Eligibility: 65 Years and older
Enrollment: 101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Autoimmune Encephalitis, Encephalitis
Interventions: Inebilizumab, Placebo; Drug
Lead sponsor: University of Utah; Other
Eligibility: 12 Years and older
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 35
States / cities: Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 28 more

Conditions: Eating Disorder Not Otherwise Specified
Interventions: Screening Questionnaire, Pre-Intervention Questionnaires (~10 minutes), SSI (Single-session intervention (~30 minutes) Active arm, SSI (Single-session intervention (~30 minutes) control arm, End-of-Intervention Questionnaires (~5 minutes); Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 22 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Oral Cancer, Squamous Cell Carcinoma
Interventions: Pressure and stretch sensitivity testing; Behavioral
Lead sponsor: New York University; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), AML Arising From Antecedent Hematologic Disorder (AHD), AML Arising After Exposure to Genotoxic Injury
Interventions: AG-120, AG-221, cytarabine, daunorubicin, idarubicin, mitoxantrone, etoposide; Drug
Lead sponsor: Institut de Recherches Internationales Servier; Other
Eligibility: 18 Years and older
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2026
U.S. locations: 14
States / cities: Duarte, California • Los Angeles, California • Aurora, Colorado + 10 more

Conditions: Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
Interventions: AZD9291 80 mg/40 mg + placebo, Placebo Erlotinib 150/100mg, Placebo Gefitinib 250 mg, Erlotinib 150/100 mg, Gefitinib 250 mg, Placebo AZD9291 80 mg/ 40 mg; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 674 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2025
U.S. locations: 14
States / cities: Anaheim, California • Santa Rosa, California • West Hills, California + 10 more

Conditions: Postoperative Pain After Uterine Fibroid Embolization, Uterine Fibroids (UF), Uterine Fibroids, Pelvic Pain, Pain Management
Interventions: TUNES (Transmucosal Uterosacral Electrical Stimulation), Sham TUNES Device; Device
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 28 Years to 52 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Health Care Transition Readiness, Health Literacy, Self Efficacy, Emotional Wellbeing, Appointment Attendance
Interventions: Health Education Videos, GotTransition.org Website; Behavioral
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 12 Years to 17 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Vaccine Hesitancy
Interventions: Storytelling, Learn More (Active Comparator); Behavioral
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years to 105 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Asthma, Depression
Interventions: SAMBA, Cognitive Behavioral Therapy-Asthma Depression (CBT-AD), Original SAMBA; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 60 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Suicide Ideation, Depression, Family Conflict
Interventions: Attachment Based Family Therapy, Enhanced Usual Care; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 12 Years to 17 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Apnea of Prematurity, Intermittent Hypoxemia, Bradycardia
Interventions: Womb sound recordings; Other
Lead sponsor: Case Western Reserve University; Other
Eligibility: 1 Week to 5 Weeks
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Surgical Incisions
Interventions: Eversion, Approximation; Procedure
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Syphilis
Interventions: Doxycycline 200mg daily for 14 days; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Hyperglycemia, Cardiovascular Disease
Interventions: Green Tea Concentrate; Dietary Supplement
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 30 Years · Male only
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Pulmonary Disease, Chronic Obstructive, Heart Failure
Interventions: Pharmacist Counseling; Procedure
Lead sponsor: Wilkes University; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Scranton, Pennsylvania

Conditions: Infant Behavior, Feeding Behavior, Breastfeeding, Pediatric Obesity
Interventions: Baby Behavior; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older · Female only
Enrollment: 423 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Davis, California

Conditions: Spasticity With Multiple Sclerosis
Interventions: Nabiximols, Placebo; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 6
States / cities: Denver, Colorado • Naples, Florida • Tampa, Florida + 3 more

Conditions: Stroke
Interventions: Surface functional electrical stimulation (FES), Motor learning, Brain computer interface (BCI) training; Other
Lead sponsor: Louis Stokes VA Medical Center; Federal
Eligibility: 22 Years and older
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Alcoholism, Sleep Initiation and Maintenance Disorders
Interventions: Quetiapine XR, Placebo.; Drug
Lead sponsor: Subhajit Chakravorty; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Anorexia Nervosa
Interventions: SilverCloud Health Mobile Intervention, Social Networking Intervention: Facebook; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 3
States / cities: Palo Alto, California • St Louis, Missouri • New York, New York

Search by objective public record fields.

A Prospective Study of a New Non-Invasive Cardiac Output Monitor in Children Undergoing General Anesthesia

The Role of Mechanical Diagnosis and Therapy in the Management of Concussion

Medipore Tape Study

Dose Response Study of Aerobic Exercise in Older Adults

The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis

A Single-session Intervention Adaptation of the Habit Framework for the Prevention of Eating Disorders

Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation

AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Transmucosal Uterosacral Electrical Stimulation for Pelvic Pain Relief

Health Care Transition Readiness Short-Form Video Intervention

COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color

R34 Asthma Depression

Family Therapy as Hospital Aftercare for Adolescent Suicide Attempters

The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants

The Effect of Wound Edge Eversion on Cosmesis

Daily Doxycycline for Early Syphillis

Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction

Improving Medication Adherence Through a Transitional Care Pharmacy Practice Model

Supporting Baby Behavior Through Pediatric Offices

Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis

Non-Invasive Brain Signal Training to Induce Motor Control Recovery After Stroke

The Effects of Quetiapine (Seroquel XR) on Sleep During Alcohol Abstinence

Helping HAND: Healing Anorexia Nervosa Digitally